Key result
Aortic valve neocuspidization yields ~97% 3-year freedom from infective endocarditis, with active endocarditis driving risk.
Why the study?
The study was conducted to evaluate the incidence and identify risk factors for infective endocarditis following aortic valve neocuspidization.
Aortic valve neocuspidization (Ozaki procedure) demonstrates a low 3-year rate of infective endocarditis, though risk is significantly elevated in patients operated on for active IE or with a history of PCI.
Low IE rates after neocuspidization may inform selection; leaves open need for RCTs and risk-stratified validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Enginoev et al. (2022) studied this question. Aortic valve neocuspidization showed a 96.6% 3-year freedom from infective endocarditis, with surgery for active endocarditis (RR 16.5) and prior PCI (RR 11.6) as major risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: